BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 16391438)

  • 1. Serum ferritin in renal cell carcinoma: effect of tumor size, volume grade, and stage.
    Singh KJ; Singh SK; Suri A; Vijjan V; Goswami AK; Khullar M
    Indian J Cancer; 2005; 42(4):197-200. PubMed ID: 16391438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of postoperative C-reactive protein level in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy.
    Tatokoro M; Saito K; Iimura Y; Fujii Y; Kawakami S; Kihara K
    J Urol; 2008 Aug; 180(2):515-9. PubMed ID: 18550105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes following partial nephrectomy by tumor size.
    Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
    J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real indications for adrenalectomy in renal cell carcinoma.
    Moudouni SM; En-Nia I; Patard JJ; Manunta A; Guillé F; Lobel B
    Scand J Urol Nephrol; 2002; 36(4):273-7. PubMed ID: 12201919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of serum ferritin in patients with renal cell carcinoma.
    Ozen H; Uygur C; Sahin A; Tekgül S; Ergen A; Remzi D
    Urology; 1995 Oct; 46(4):494-8. PubMed ID: 7571217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative prognostic nomogram (probability table) for renal cell carcinoma based on TNM classification.
    Kanao K; Mizuno R; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Nakashima J; Oya M
    J Urol; 2009 Feb; 181(2):480-5; discussion 485. PubMed ID: 19100568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.
    Leibovich BC; Cheville JC; Lohse CM; Zincke H; Frank I; Kwon ED; Merchan JR; Blute ML
    J Urol; 2005 Nov; 174(5):1759-63; discussion 1763. PubMed ID: 16217278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating tumor M2 pyruvate kinase and thymidine kinase 1 are potential predictors for disease recurrence in renal cell carcinoma after nephrectomy.
    Nisman B; Yutkin V; Nechushtan H; Gofrit ON; Peretz T; Gronowitz S; Pode D
    Urology; 2010 Aug; 76(2):513.e1-6. PubMed ID: 20573390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
    Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C; Song C; Hong JH; Kim CS; Ahn H
    J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma.
    Komai Y; Saito K; Sakai K; Morimoto S
    BJU Int; 2007 Jan; 99(1):77-80. PubMed ID: 16956357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive acidic protein detects high nuclear grade localized renal cell carcinoma.
    Kawata N; Yamaguchi K; Hirakata H; Hachiya T; Yoshida T; Takimoto Y
    Urology; 2005 Oct; 66(4):736-40. PubMed ID: 16230127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality: a European study of 313 patients.
    Karakiewicz PI; Hutterer GC; Trinh QD; Jeldres C; Perrotte P; Gallina A; Tostain J; Patard JJ
    Cancer; 2007 Sep; 110(6):1241-7. PubMed ID: 17639589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of C-reactive protein kinetics on survival of patients with metastatic renal cell carcinoma.
    Saito K; Tatokoro M; Fujii Y; Iimura Y; Koga F; Kawakami S; Kihara K
    Eur Urol; 2009 May; 55(5):1145-53. PubMed ID: 18930583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic risk stratification and clinical outcomes in patients undergoing surgical treatment for renal cell carcinoma with vascular tumor thrombus.
    Lambert EH; Pierorazio PM; Shabsigh A; Olsson CA; Benson MC; McKiernan JM
    Urology; 2007 Jun; 69(6):1054-8. PubMed ID: 17572185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cathepsin D serum levels are not a valid serum marker in renal cell carcinoma.
    Merseburger AS; Hennenlotter J; Stenzl A; Beger G; Rinnab L; Kuczyk MA; Kuefer R
    Urol Int; 2007; 79(1):41-3. PubMed ID: 17627167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score.
    Iimura Y; Saito K; Fujii Y; Kumagai J; Kawakami S; Komai Y; Yonese J; Fukui I; Kihara K
    J Urol; 2009 Mar; 181(3):1004-12; discussion 1012. PubMed ID: 19150550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCR3-B expression correlates with tumor necrosis extension in renal cell carcinoma.
    Gacci M; Serni S; Lapini A; Vittori G; Alessandrini M; Nesi G; Palli D; Carini M
    J Urol; 2009 Feb; 181(2):843-8. PubMed ID: 19095263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of clinical variables on predicting disease-free survival of patients with surgically resected renal cell carcinoma.
    Brookman-Amissah S; Kendel F; Spivak I; Pflanz S; Roigas J; Klotz T; May M
    BJU Int; 2009 May; 103(10):1375-80. PubMed ID: 19040527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional and oncological outcomes of partial nephrectomy of solitary kidneys.
    La Rochelle J; Shuch B; Riggs S; Liang LJ; Saadat A; Kabbinavar F; Pantuck A; Belldegrun A
    J Urol; 2009 May; 181(5):2037-42; discussion 2043. PubMed ID: 19298974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.